Tonga Nfor, MD
Interventional Cardiology · Milwaukee, WINPI 1821277724
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $834 of the $946 with a category attached, or 88.1%. 4 manufacturers reported payments, led by Abiomed at 42.5% of the total. Reporting peaked in 2022 at $512 and has fallen 61.6% since, to $197 in 2025. That places this record below the midpoint for interventional cardiology clinicians in WI, where the typical reported total is $3,713.
Across 11 payments — averaging $86.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$402
- Boston Scientific$261
- Abbott$213
- Penumbra, Inc.$70
Across 13 payments — averaging $2062.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$27K
What the payments were for
- Food & beverage$83488%
- Gifts$11212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 4 | $402 |
| Boston Scientific | 3 | $261 |
| Abbott | 3 | $213 |
| Penumbra, Inc. | 1 | $70 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$343
- GENERAL ATHERECTOMY$134
- CARDIOMEMS$101
How this compares
$946 in reported general payments places this provider in the 25th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 362 | $428,973 |
| JardianceEmpagliflozin | 128 | $149,932 |
| XareltoRivaroxaban | 146 | $146,425 |
| EntrestoSacubitril/Valsartan | 95 | $100,617 |
| BrilintaTicagrelor | 34 | $29,650 |
| Repatha SureclickEvolocumab | 40 | $28,707 |
| Metoprolol Succinate | 959 | $13,022 |
| Atorvastatin Calcium | 1,226 | $9,707 |
| ClopidogrelClopidogrel Bisulfate | 416 | $4,480 |
| Losartan Potassium | 533 | $3,986 |
| Clonidine | 15 | $3,503 |
| Furosemide | 562 | $3,475 |
| Nifedipine ErNifedipine | 131 | $3,431 |
| Amiodarone Hcl | 96 | $3,080 |
| Carvedilol | 398 | $2,996 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Milwaukee
- Michael SalingerMilwaukee$216K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
- Saif AnwaruddinMilwaukee$80K
- Iyad AzzamMilwaukee$60K
- Montoya TaylorMilwaukee$48K
- Mina IskanderMilwaukee$41K
- Anna LarosaMilwaukee$38K
- Louie KostopoulosMilwaukee$26K
- Daniel JohnsrudMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.